Cytosorbents (CTSO) Change in Inventory (2011 - 2026)
Cytosorbents (CTSO) posted Change in Inventory of -$723000.0 for Q1 2026, down 155.92% on a QoQ basis from $1.3 million in Q4 2025, and down 463.32% year-over-year from $199000.0 in Q1 2025.
Cytosorbents (CTSO) Change in Inventory (2011 - 2026) Analysis & Trends
Cytosorbents' Change in Inventory history runs 16 years deep, the most recent figure standing at -$723000.0 for Q1 2026.
- Quarterly Change in Inventory fell 463.32% year-over-year to -$723000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.6 million (up 321.38% YoY) and the FY2025 annual result came in at $2.5 million, up 608.0% from the prior year.
- Change in Inventory was -$723000.0 for Q1 2026 at Cytosorbents, down from $1.3 million in the prior quarter.
- Across five years, Change in Inventory topped out at $1.3 million in Q4 2025 and bottomed at -$1.7 million in Q1 2023.
- A 5-year average of $11080.9 and a median of $288549.0 in 2023 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2025 — Change in Inventory soared 472.62% — and 2026, when it tumbled 463.32%.
- Cytosorbents' Change in Inventory stood at -$485918.0 in 2022, then jumped by 159.38% to $288549.0 in 2023, then tumbled by 220.26% to -$347000.0 in 2024, then surged by 472.62% to $1.3 million in 2025, then slumped by 155.92% to -$723000.0 in 2026.
- Business Quant data shows CTSO's Change in Inventory at -$723000.0 in Q1 2026, $1.3 million in Q4 2025, and $322000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 420.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 127.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -399.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 65.20 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -264.59 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 171.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Cytosorbents | 22.58 Mn | 17.78 Mn | 6.13 Mn | -723,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -723,000.00 |
| Mar 31, 2026 | -723,000.00 |
| Dec 31, 2025 | 1.29 Mn |
| Dec 31, 2025 | 1.29 Mn |
| Sep 30, 2025 | 322,000.00 |
| Sep 30, 2025 | 322,000.00 |
| Jun 30, 2025 | 726,000.00 |
| Jun 30, 2025 | 726,000.00 |
| Mar 31, 2025 | 199,000.00 |
| Mar 31, 2025 | 199,000.00 |
| Dec 31, 2024 | -347,000.00 |
| Dec 31, 2024 | -347,000.00 |
| Sep 30, 2024 | -1.18 Mn |
| Sep 30, 2024 | -1.18 Mn |
| Jun 30, 2024 | 600,131.00 |
| Jun 30, 2024 | 600,131.00 |
| Mar 31, 2024 | 429,869.00 |
| Mar 31, 2024 | 429,869.00 |
| Dec 31, 2023 | 288,549.00 |
| Dec 31, 2023 | 288,549.00 |